Skip to main content
Medicine logoLink to Medicine
. 2022 Nov 25;101(47):e31981. doi: 10.1097/MD.0000000000031981

Magnetic resonance imaging for predicting delayed neurologic sequelae caused by carbon monoxide poisoning: A systematic review and meta-analysis

Shun Yi Feng a,*
PMCID: PMC9704964  PMID: 36451422

Background:

This study summarized and analyzed the prognostic value of magnetic resonance imaging (MRI) for delayed neurologic sequelae (DNS) caused by carbon monoxide (CO) poisoning.

Methods:

PubMed, China National Knowledge Infrastructure, and Wanfang Database were searched to identify relevant articles from their inception to October 30, 2022. The pooled sensitivity and specificity were estimated to investigate MRI for predicting DNS.

Results:

6 studies comprising 635 participants were identified as eligible for the present analysis. The pooled sensitivity and specificity of MRI were 0.72 (95% CI: 0.62–0.81) and 0.80 (95% CI: 0.71–0.86), respectively. The findings of sensitivity analyses proved that the overall results were robust, and no publication bias was detected (P = .49).

Conclusion:

Based on current evidence, MRI may be useful in determining DNS caused by acute CO poisoning.

Keywords: carbon monoxide, delayed neurologic sequelae, magnetic resonance imaging, prognosis

1. Introduction

Carbon monoxide (CO) is a gaseous molecule that occurs ubiquitously in nature as the product of organic combustion processes. CO poisoning is attributed to the affinity of CO and hemoglobin that is 250 times higher than that of oxygen and hemoglobin[1] and the highly stable carboxyhemoglobin that is not easily dissociated, resulting in hypoxia of the whole body. Acute CO poisoning causes symptoms, such as headaches, dizziness, nausea, and vomiting. In severe cases, it may cause unconsciousness, respiratory arrest, and death.[25] Delayed neurologic sequelae (DNS) caused by acute CO intoxication poses considerable treatment challenges for clinical practitioners. It was estimated that up to 30% of patients result in DNS complications after acute CO poisoning despite aggressive treatment.[69]

DNS is pathologically characterized by the demyelination of white matter with cytotoxic edema.[10,11] Novel magnetic resonance imaging (MRI) sequences such as diffusion-weighted imaging and diffusion tensor imaging can objectively and quantitatively indicate the magnitude and directionality of water molecular diffusion in tissues.[11] Cerebral edema changes occur early with the subsequent demonstration of globus pallidus lesions and white matter changes. Although MRI for predicting the development of DNS have been studied, no consistent results have been identified. Hence, a comprehensive systematic review and meta-analysis were performed to determine prognostic value of MRI for predicting DNS caused by CO poisoning.

2. Methods

2.1. Study design

The current meta-analysis was based entirely on previous published guidance for the Preferred Reporting Items for Systematic Reviews and Meta-analysis statement[12] and no original clinical raw data were collected or utilized, and thus, ethical approval was not sought for this study.

2.2. Literature search

A systematic search was performed in PubMed, China National Knowledge Infrastructure, and Wanfang Database to identify relevant articles that investigated the clinical predictive methods of DNS caused by CO poisoning from their inception to October 30, 2022. The search strategy included: “carbon monoxide [Title],” magnetic resonance imaging [Title/abstract], “sensitivity” and “specificity”). Additionally, the reference lists of relevant reviews and the articles selected for inclusion were further manually searched.

2.3. Inclusion and exclusion criteria

All the included studies were selected if they met the following criteria: research evaluated clinical predictive methods and delayed neurologic sequelae; and sufficient data were available for calculating pooled sensitivity and specificity with their 95% confidence interval (CI).

The exclusion criteria included: conference papers, meta-analysis, or review; duplicated data; not present the usable data; animal experiments; and unavailable full-text.

2.4. Data extraction and quality assessment

According to the unified inclusion and exclusion criteria, after the preliminary screening of the literature, the data of the included literature were extracted independently by 2 researchers and cross-checked to determine data accuracy. Baseline data extracted included first author and publication time, region, study type, sample size, age, prevalence of DNS, sensitivity, and specificity.

The quality assessment of diagnostic accuracy studies-2 (QUADAS-2)[13] checklist was used to assess the methodological quality of the included studies as recommended by the Cochrane Collaboration.

2.5. Statistical analysis

The data were analyzed using Stata version 11.0 (Stata Corporation, College Station, TX). Tests with P ≤ .1 or I2 > 50% indicated significant heterogeneity. If there was obvious heterogeneity among the studies, a fixed-effect model was applied for analysis. Otherwise, a random-effect model was used. Sensitivity analysis was conducted to test the robustness of pooled outcomes of these studies by removing an individual study in sequence. Publication bias was examined by funnel plots, and Egger tests were employed for evaluating the degree of asymmetry. P-value < .05 was considered significant.

3. Results

3.1. Literature search and selection

The retrieval process for eligible studies is summarized in Fig. 1. According to the search strategy, 142 potentially relevant studies in the electronic databases and initially 34 duplicated publications were excluded. After the title, abstract, and full text were reviewed, 38 publications did not focus on MRI for predicting DNS and 14 had no unavailable data. Finally, 6 studies[1419] were included according to the study inclusion and exclusion criteria.

Figure 1.

Figure 1.

PRISMA flowchart of studies retrieved, screened, and selected for further analysis.

3.2. Characteristics of the included studies

The main information obtained from the included studies is shown in Table 1. All of the selected articles comprising 635 patients were published in English or Chinese with the posting time ranged from 2018 to 2021. All the studies were performed in Asia. Of these studies, 4 used diffusion-weighted imaging,[1416,18] 1 used diffusion tensor imaging,[17] and 1 used diffusion kurtosis imaging.[19] The mean sample size of the studies was 106, ranging from 52 to 183. The total incidence of DNS was 32.6%.

Table 1.

Characteristics of the included studies.

Author (Yr) Region Design Mean age Male
(%)
Method Sample size DNS (%) Sensitivity
(%)
Specificity
(%)
Jeon 2018 Korea Prospective 42.0 (32.0–56.0) 63.0 Diffusion-weighted imaging 104 73.1 0.752 0.902
Kim 2018 Korea Retrospective 55.5 (36.8–69) 57.8 Diffusion-weighted imaging 102 9.80 0.700 0.804
Kokulu 2020 Turkey Prospective 38.0 (28.0–53.0) 60.1 Diffusion-weighted imaging 183 29.5 0.722 0.868
Liu 2019 China Retrospective 48.5 ± 15.6 45.4 Diffusion tensor imaging 119 26.1 0.487 0.842
Suzuki 2021 Japan Retrospective 46 (35–61) 69.0 Diffusion-weighted imaging 52 42.3 0.790 0.710
Zhang 2020 China Prospective 47.4 ± 9.70 49.3 Diffusion kurtosis imaging 75 28.6 0.818 0.604

Categorical variables are expressed as numbers (%) and continuous variables are expressed as means, means ± standard deviations or medians (interquartile ranges), as appropriate.

DNS = delayed neurologic sequelae.

3.3. Quality assessment

The quality assessment of the included studies is summarized in Fig. 2. With regard to patient selection, 4 (66.7%) patients were at a high or unclear risk of bias because they did not specify patient selection methodology (random or consecutive).[14,1719] With regard to index text, 5 (83.3%) were at an unclear risk of bias with regard to the index text during blinding or not during sample analysis.[14,15,1719] With regard to patient flow and time domains, 1 (66.7%) patients was at a high risk of bias, as not all selected patients received MRI.[14]

Figure 2.

Figure 2.

Summary of risk of bias and applicability concerns obtained from the QUADAS-2 tool for 6 studies included in meta-analysis. QUADAS-2 = quality assessment of diagnostic accuracy studies-2.

3.4. Main results

The meta-analysis demonstrated a pooled sensitivity of 0.72 (95% CI: 0.62–0.81, Fig. 3A) and a pooled specificity of 0.80 (95% CI: 0.71–0.86, Fig. 3B). Figure 4 shows the summary receiver operating characteristic curve, and the AUC was 0.83 (95% CI: 0.79–0.86).

Figure 3.

Figure 3.

Forest plot of sensitivity and specificity of MRI for predicting DNS. (a) Sensitivity; (b) specificity. MRI = magnetic resonance imaging; DNS = delayed neurologic sequelae.

Figure 4.

Figure 4.

Summary receiver operating characteristic curve of MRI for predicting DNS. MRI: magnetic resonance imaging; DNS: delayed neurologic sequelae.

3.5. Sensitivity analysis and publication bias

Sensitivity analyses were conducted to determine whether modifications in the inclusion criteria of the meta-analysis affected the results, and the result was stable (Fig. 5). Deeks’ tests indicated no evidence of significant publication bias after assessing the funnel plot for the studies included in our meta-analysis (P = .49; Fig. 6).

Figure 5.

Figure 5.

Sensitivity analysis of the association between MRI and DNS. MRI: magnetic resonance imaging; DNS: delayed neurologic sequelae.

Figure 6.

Figure 6.

Deek’s asymmetry plot showed no publication bias among the included studies.

4. Discussion

In general, DNS caused by acute CO poisoning is characterized by a difficult early diagnosis and poor prognosis. The majority of patients are at a high risk of progressive stage at the time of diagnosis, indicating that brain function was impaired, and a poor prognosis follows. Precise prognostic forecast of patients with acute CO poisoning is critical for making further management decisions. In this study, DNS developed in 29.2% of our patients, which is consistent with previous research[6,14,20] Our findings showed that the AUC of MRI for predicting DNS caused by CO poisoning was 0.83 (95% CI: 0.79–0.86), with 72% sensitivity and 80% specificity, which indicate that MRI is a good prediction method.

The diagnosis of DNS is primarily made on the basis of the clinical features and radiological findings of CT and conventional MRI. Higher CO exposure levels and longer-duration exposure are associated with more severe symptoms and a greater likelihood of developing DNS. Unfortunately, determining which patients will develop DNS in a clinical setting is difficult with the use of CO exposure levels and exposure duration due to inaccuracies in establishing the exact exposure duration and the CO level at the time of exposure. Initial GCS scores were lower in patients who developed poor neurological outcomes than in patients who developed good neurological outcomes. However, it is important to consider that CO-poisoned patients could have taken drugs and/or alcohol, which can also affect their level of consciousness. As such, diagnosis requires objective indicators.

Brain lesions caused by CO poisoning can be seen using MRI in both acute and chronic phases. The pathological features of acute phase are characterized by altered signal intensity areas involving the globus pallidus bilaterally, which display T1WI low signal and T2WI high signal[2124] DWI and apparent diffusion coefficient maps usually reveal areas of restricted diffusivity in the globus pallidus, as for cytotoxic edema[25] Follow-up MRI revealed extensive involvement of the basal ganglion structures, which displayed diffuse hypodense areas as a result of extensive demyelination. In more severe cases, these features can extend to involve the internal and external capsules, corpus callosum, and subcortical white matter.

To date, most investigations that used MRI have been focused on either diffusion-weighted imaging[1416,18] or diffusion tensor imaging[17,26] as the sites of typical lesions after CO poisoning. However, pathological changes in the acute phase were too small to observe conventional MRI and diffusion-weighted imaging or diffusion tensor imaging in most patients. Novel MRI techniques are emerging, which enable doctors to detect subtle changes in cerebral tissue composition and cell metabolism. Xu et al demonstrated that the glutamate chemical exchange saturation transfer MRI non-invasively reflected the changes in glutamate content in the rat brain with higher sensitivity and spatial resolution and provided a pathogenetic and prognostic assessment of CO-associated encephalopathy.[27] Future studies would benefit from the use of latest technological developments to identify individuals at risk of dementia and new intervention strategies.

This meta-analysis has several limitations. Some signatures were designed to optimize sensitivity, while others were designed to optimize specificity. As such, bias may have been introduced in the pooled estimates of sensitivity and specificity in the meta-analysis. Our analysis might overestimate the prognostic significance of MRI to some degree due to the positive results reported in most of the included publications.

5. Conclusion

This systematic review and meta-analysis elucidated the prognostic value of MRI for DNS caused by carbon monoxide poisoning. The findings illustrate that MRI may serve as effective predictive tools for DNS. Future large-scale prospective and standard investigations should be conducted to confirm our results.

Author contributions

Conceptualization: Shun Yi Feng.

Software: Shun Yi Feng.

Writing – original draft: Shun Yi Feng.

Writing – review & editing: Shun Yi Feng.

Abbreviations:

CO =
carbon monoxide
DNS =
delayed neurologic sequelae
MRI =
magnetic resonance imaging

The authors have no funding and conflicts of interest to disclose.

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

How to cite this article: Feng SY. Magnetic resonance imaging for predicting delayed neurologic sequelae caused by carbon monoxide poisoning: A systematic review and meta-analysis. Medicine 2022;101:47(e31981).

References

  • [1].Ernst A, Zibrak JD. Carbon monoxide poisoning. N Engl J Med. 1998;339:1603–8. [DOI] [PubMed] [Google Scholar]
  • [2].Onodera M, Tsukada Y, Suzuki T, et al. Development of delayed neurologic sequelae in acute carbon monoxide poisoning cases caused by briquette-based kotatsu: a case-control study. Medicine (Baltim). 2021;100:e25009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3].Choi S, Han S, Nah S, et al. Effect of ethanol in carbon monoxide poisoning and delayed neurologic sequelae: a prospective observational study. PLoS One. 2021;16:e0245265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].Tian X, Guan T, Guo Y, et al. Selective susceptibility of oligodendrocytes to carbon monoxide poisoning: Implication for delayed neurologic sequelae (DNS). Front Psychiatry. 2020;11:815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [5].Kuroda H, Fujihara K, Kushimoto S, et al. Novel clinical grading of delayed neurologic sequelae after carbon monoxide poisoning and factors associated with outcome. Neurotoxicology. 2015;48:35–43. [DOI] [PubMed] [Google Scholar]
  • [6].Pepe G, Castelli M, Nazerian P, et al. Delayed neuropsychological sequelae after carbon monoxide poisoning: predictive risk factors in the Emergency Department. A retrospective study. Scand J Trauma Resusc Emerg Med. 2011;19:16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [7].Ku HL, Yang KC, Lee YC, et al. Predictors of carbon monoxide poisoning-induced delayed neuropsychological sequelae. Gen Hosp Psychiatry. 2010;32:310–4. [DOI] [PubMed] [Google Scholar]
  • [8].Annane D, Chadda K, Gajdos P, et al. Hyperbaric oxygen therapy for acute domestic carbon monoxide poisoning: two randomized controlled trials. Intensive Care Med. 2011;37:486–92. [DOI] [PubMed] [Google Scholar]
  • [9].Weaver LK, Valentine KJ, Hopkins RO. Carbon monoxide poisoning: risk factors for cognitive sequelae and the role of hyperbaric oxygen. Am J Respir Crit Care Med. 2007;176:491–7. [DOI] [PubMed] [Google Scholar]
  • [10].Tsuneya S, Makino Y, Chiba F, et al. Postmortem magnetic resonance imaging revealed bilateral globi pallidi lesions in a death associated with prolonged carbon monoxide poisoning: a case report. Int J Legal Med. 2021;135:921–8. [DOI] [PubMed] [Google Scholar]
  • [11].Beppu T. The role of MR imaging in assessment of brain damage from carbon monoxide poisoning: a review of the literature. AJNR Am J Neuroradiol. 2014;35:625–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [12].Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Schueler S, Schuetz GM, Dewey M. The revised QUADAS-2 tool. Ann Intern Med. 2012;156:323. [DOI] [PubMed] [Google Scholar]
  • [14].Jeon SB, Sohn CH, Seo DW, et al. Acute brain lesions on magnetic resonance imaging and delayed neurological sequelae in carbon monoxide poisoning. JAMA Neurol. 2018;75:436–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Kim YS, Cha YS, Kim MS, et al. The usefulness of diffusion-weighted magnetic resonance imaging performed in the acute phase as an early predictor of delayed neuropsychiatric sequelae in acute carbon monoxide poisoning. Hum Exp Toxicol. 2018;37:587–95. [DOI] [PubMed] [Google Scholar]
  • [16].Kokulu K, Mutlu H, Sert ET. Serum netrin-1 levels at presentation and delayed neurological sequelae in unintentional carbon monoxide poisoning. Clin Toxicol (Phila). 2020;58:1313–9. [DOI] [PubMed] [Google Scholar]
  • [17].Liu YY, Liu Z, Ma Z, et al. Value of serum myelin basic protein combined with magnetic resonance spectroscopy and diffusion tensor imaging in prediction of delayed encephalopathy after acute carbon monoxide poisoning. J Clin Emerg. 2019;20:352–6. [Google Scholar]
  • [18].Suzuki Y. Risk factors for delayed encephalopathy following carbon monoxide poisoning: importance of the period of inability to walk in the acute stage. PLoS One. 2021;16:e0249395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [19].Zhang YL, Wang TH, Guo SL, et al. Diffusion kurtosis imaging in predicting delayed encephalopathy after acute carbon monoxide poisoning. Chin J Med Imag Tech. 2020;36:215–9. [Google Scholar]
  • [20].Sert ET, Kokulu K, Mutlu H. Clinical predictors of delayed neurological sequelae in charcoal-burning carbon monoxide poisoning. Am J Emerg Med. 2021;48:12–7. [DOI] [PubMed] [Google Scholar]
  • [21].Hegde AN, Mohan S, Lath N, et al. Differential diagnosis for bilateral abnormalities of the basal ganglia and thalamus. Radiographics. 2011;31:5–30. [DOI] [PubMed] [Google Scholar]
  • [22].Wang X, Li Z, Berglass J, et al. MRI and clinical manifestations of delayed encephalopathy after carbon monoxide poisoning. Pak J Pharm Sci. 2016;29:2317–20. [PubMed] [Google Scholar]
  • [23].Liu WP, Xiao B, Zhang J. Study of delayed encephalopathy after acute carbon monoxide poisoning by clinical characteristic, CT and MRI features. Hunan Yi Ke Da Xue Xue Bao. 2001;26:254–6. [PubMed] [Google Scholar]
  • [24].Guo J, Meng J, Han T. MRI-based comparison of brain damage between acute carbon monoxide poisoning and delayed encephalopathy after acute carbon monoxide poisoning. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2014;32:533–6. [PubMed] [Google Scholar]
  • [25].Sener RN. Acute carbon monoxide poisoning: diffusion MR imaging findings. AJNR Am J Neuroradiol. 2003;24:1475–7. [PMC free article] [PubMed] [Google Scholar]
  • [26].Wu J, Peng T, Xu Z, et al. Evaluation of changes in magnetic resonance diffusion tensor imaging after treatment of delayed encephalopathy due to carbon monoxide poisoning. J Integr Neurosci. 2019;18:475–9. [DOI] [PubMed] [Google Scholar]
  • [27].Xu Y, Zhuang Z, Zheng H, et al. Glutamate chemical exchange saturation transfer (GluCEST) magnetic resonance imaging of rat brain with acute carbon monoxide poisoning. Front Neurol. 2022;13:865970. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES